» Articles » PMID: 32881298

A Cross-national Study of Depression in Preclinical Dementia: A COSMIC Collaboration Study

Abstract

Introduction: Depression commonly accompanies Alzheimer's disease, but the nature of this association remains uncertain.

Methods: Longitudinal data from the COSMIC consortium were harmonized for eight population-based cohorts from four continents. Incident dementia was diagnosed in 646 participants, with a median follow-up time of 5.6 years to diagnosis. The association between years to dementia diagnosis and successive depressive states was assessed using a mixed effect logistic regression model. A generic inverse variance method was used to group study results, construct forest plots, and generate heterogeneity statistics.

Results: A common trajectory was observed showing an increase in the incidence of depression as the time to dementia diagnosis decreased despite cross-national variability in depression rates.

Discussion: The results support the hypothesis that depression occurring in the preclinical phases of dementia is more likely to be attributable to dementia-related brain changes than environment or reverse causality.

Citing Articles

Higher socioeconomic deprivation in areas predicts cognitive decline in New Zealanders without cognitive impairment.

Rohr S, Gibson R, Alpass F Sci Rep. 2024; 14(1):28314.

PMID: 39550429 PMC: 11569260. DOI: 10.1038/s41598-024-79583-w.


Artificial intelligence for dementia prevention.

Newby D, Orgeta V, Marshall C, Lourida I, Albertyn C, Tamburin S Alzheimers Dement. 2023; 19(12):5952-5969.

PMID: 37837420 PMC: 10843720. DOI: 10.1002/alz.13463.


A Novel Score for Predicting Alzheimer's Disease Risk from Late Life Psychopathological and Health Risk Factors.

Santabarbara J, Bueno-Notivol J, Lipnicki D, De la Camara C, Lopez-Anton R, Lobo A Int J Environ Res Public Health. 2021; 18(4).

PMID: 33673250 PMC: 7918511. DOI: 10.3390/ijerph18041802.


lncRNA MIR155HG Alleviates Depression-Like Behaviors in Mice by Regulating the miR-155/BDNF Axis.

Huan Z, Mei Z, Na H, Xinxin M, Yaping W, Ling L Neurochem Res. 2021; 46(4):935-944.

PMID: 33511575 DOI: 10.1007/s11064-021-03234-z.

References
1.
Calia C, Johnson H, Cristea M . Cross-cultural representations of dementia: an exploratory study. J Glob Health. 2019; 9(1):011001. PMC: 6445496. DOI: 10.7189/jogh.09.01101. View

2.
Wilson R, Hoganson G, Rajan K, Barnes L, Mendes de Leon C, Evans D . Temporal course of depressive symptoms during the development of Alzheimer disease. Neurology. 2010; 75(1):21-6. PMC: 2906401. DOI: 10.1212/WNL.0b013e3181e620c5. View

3.
Gallagher D, Kiss A, Lanctot K, Herrmann N . Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry. 2018; 26(8):819-827. PMC: 6101977. DOI: 10.1016/j.jagp.2018.05.002. View

4.
Campbell S, MacQueen G . The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci. 2005; 29(6):417-26. PMC: 524959. View

5.
Namekawa Y, Baba H, Maeshima H, Nakano Y, Satomura E, Takebayashi N . Heterogeneity of elderly depression: increased risk of Alzheimer's disease and Aβ protein metabolism. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 43:203-8. DOI: 10.1016/j.pnpbp.2012.12.016. View